Skip to content
DraconiticResearch
Search Sources API
182,460 studies31 sourcesUpdated 50 min ago
PreprintCC BYbioRxiv

The global evolutionary dynamics of natural capsule switching in a human-restricted bacterial pathogen

4 more authors
  1. 1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA

Abstract

Exchange of genetic loci encoding extracellular capsular polysaccharides in bacteria can change capsular antigens or serotype, which, in turn, can lead to evasion of vaccines targeting the capsule. However, the evolutionary dynamics and drivers of bacterial capsule switching remain poorly understood. Here, we investigate the evolutionary dynamics and correlates of capsule switching in bacteria, using the human-restricted bacterial pathogen Streptococcus pneumoniae as an example, using 10,558 genetically and geographically diverse whole-genome sequences. Our phylogenomic and ancestral state reconstruction analysis revealed that the propensity for capsule switching varies by capsule type and genetic background. We found capsule switches only between ~4% of all possible capsule-type pairs, varying by specific pairs and switching direction. We also found associations between capsule switching patterns and genetic and ecological factors, including nasopharyngeal carriage duration, capsule biosynthesis locus size, and capsule thickness. Furthermore, the genetic similarity of the replacing and replaced capsule loci was primarily associated with the frequency of switching between specific capsule type pairs. Although a few specific non-capsule genomic loci were associated with the propensity for capsule switching across distinct lineages, the collective effect of the genetic background appears to influence capsule switching more strongly. These findings shed light on how bacterial capsule types and lineages undergo capsule switching influenced by genetic and ecological factors, informing our understanding of the emergence of novel capsule-genotype combinations that may impact the design of capsule-targeting glycoconjugate vaccines.

Related

  1. Short gene overlaps in bacterial genomes: evolutionary dynamics and functional associations
    A. Sukhodolsky, M. Gelfand, A. Kaznadzey
    bioRxivPreprintCC BYFull textEvolutionary biologybioRxiv
  2. Global rise of a wheat pathogen through two-stage evolutionary emergence coupled with aerial dispersal
    Siyue Zhang, Yuxiang Li, Gangming Zhan +27
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textPlant biologyCrossref
  3. The bacterial pathogen causing cucurbit yellow vine disease associates with the specialized extrafascicular phloem unique to cucurbits
    K. Mphande, B. LaSarre, M. L. Gleason +1
    bioRxivPreprintAll rights reservedFull textPlant biologybioRxiv
  4. The resveratrol monomer enhances resistance to bacterial pathogen through the activation of SA-NPR1 signaling pathway in Arabidopsis
    Yuqiao Ma, Sun Ho Kim, Minh Le Anh Pham +5
    Frontiers in plant sciencePeer-reviewedCC BYFull textPlant biologyEurope PMC
  5. Lowly polymorphic pathogen proteins may not be under evolutionary constraint
    A. Pinharanda, S. A. Perkins, A. M. Early +1
    bioRxivPreprintCC BYFull textEvolutionary biologybioRxiv
BibTeX
@misc{chaguza2026global,
  title = {{The global evolutionary dynamics of natural capsule switching in a human-restricted bacterial pathogen}},
  author = {C. Chaguza and A. York and S. W. Lo and A. Kalizang'oma and R. A. Gladstone and B. A. Kwambana-Adams and R. Cave and Global Pneumococcal Sequencing (GPS) Consortium and K. P. Klugman and C. P. Andam and R. S. Heyderman and L. McGee and J. W. Rosch and N. J. Croucher and S. D. Bentley and D. M. Weinberger},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.24.752487},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.24.752487v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - The global evolutionary dynamics of natural capsule switching in a human-restricted bacterial pathogen
AU  - C. Chaguza
AU  - A. York
AU  - S. W. Lo
AU  - A. Kalizang'oma
AU  - R. A. Gladstone
AU  - B. A. Kwambana-Adams
AU  - R. Cave
AU  - Global Pneumococcal Sequencing (GPS) Consortium
AU  - K. P. Klugman
AU  - C. P. Andam
AU  - R. S. Heyderman
AU  - L. McGee
AU  - J. W. Rosch
AU  - N. J. Croucher
AU  - S. D. Bentley
AU  - D. M. Weinberger
PY  - 2026
DA  - 2026/09/24
PB  - bioRxiv
DO  - 10.64898/2026.09.24.752487
UR  - https://www.biorxiv.org/content/10.64898/2026.09.24.752487v1
AB  - Exchange of genetic loci encoding extracellular capsular polysaccharides in bacteria can change capsular antigens or serotype, which, in turn, can lead to evasion of vaccines targeting the capsule. However, the evolutionary dynamics and drivers of bacterial capsule switching remain poorly understood. Here, we investigate the evolutionary dynamics and correlates of capsule switching in bacteria, using the human-restricted bacterial pathogen Streptococcus pneumoniae as an example, using 10,558 genetically and geographically diverse whole-genome sequences. Our phylogenomic and ancestral state reconstruction analysis revealed that the propensity for capsule switching varies by capsule type and genetic background. We found capsule switches only between ~4% of all possible capsule-type pairs, varying by specific pairs and switching direction. We also found associations between capsule switching patterns and genetic and ecological factors, including nasopharyngeal carriage duration, capsule biosynthesis locus size, and capsule thickness. Furthermore, the genetic similarity of the replacing and replaced capsule loci was primarily associated with the frequency of switching between specific capsule type pairs. Although a few specific non-capsule genomic loci were associated with the propensity for capsule switching across distinct lineages, the collective effect of the genetic background appears to influence capsule switching more strongly. These findings shed light on how bacterial capsule types and lineages undergo capsule switching influenced by genetic and ecological factors, informing our understanding of the emergence of novel capsule-genotype combinations that may impact the design of capsule-targeting glycoconjugate vaccines.
ER  -